Literature DB >> 11264757

Influence of body fat distribution on oxygen uptake and pulmonary performance in morbidly obese females during exercise.

J Li1, S Li, R J Feuers, C K Buffington, G S Cowan.   

Abstract

OBJECTIVE: The aim of this study was to determine the effects of fat distribution on aerobic and ventilatory response to exercise testing in morbidly obese (MO) females.
METHODOLOGY: The study population consisted of 164 MO females, 55% (n = 90) with upper body or abdominal adiposity (UBD), as defined by waist-hip circumference ratio (WHR) > or = 0.80, and 45% (n = 74) with lower body fat distribution (LBD) (WHR < 0.80). An incremental exercise testing on cycle ergometer was performed to determine the effect of exercise on oxygen consumption (VO2), carbon dioxide production (VCO2), minute ventilation (VE), tidal volume (VT), respiratory rate (fb) and heart rate (HR).
RESULTS: Upper body adiposity individuals had significantly higher VO2 and VCO2 than LBD subjects (P < 0.05) from 0 watt (W) of pedalling up to their anaerobic threshold (AT) and maximal exercise. VE was significantly higher in UBD subjects compared with LBD subjects, from 20 W during exercise up to AT and peak work levels (P < 0.05). Upper body adiposity group also had a significantly higher fb than the LBD group at rest, after each workload and at AT and peak exercise work rates (P < 0.05). VT was lower in UBD subjects at free pedalling and up to AT and peak workload with significant difference at 60 and 80 W (P < 0.05). The anaerobic threshold, expressed as work rate, was significantly lower in the UBD subjects (P < 0.05) and peak workload achieved did not differ significantly between the two groups.
CONCLUSIONS: Upper body adiposity subjects had higher oxygen requirement, more rapid and shallow breathing, higher ventilatory demand, but lower anaerobic threshold than the LBD individuals during progressive exercise. It suggests that the cardiopulmonary endurance to exercise in MO patients with upper body fat distribution is lower than in those with lower body fat distribution.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11264757     DOI: 10.1046/j.1440-1843.2001.00290.x

Source DB:  PubMed          Journal:  Respirology        ISSN: 1323-7799            Impact factor:   6.424


  5 in total

1.  Ventilatory and Metabolic Response in the Incremental Shuttle and 6-Min Walking Tests Measured by Telemetry in Obese Patients Prior to Bariatric Surgery.

Authors:  Nicole Oliver; Tatiana Onofre; Renata Carlos; Juliana Barbosa; Eudes Godoy; Eliane Pereira; Ricardo O Guerra; Selma Bruno
Journal:  Obes Surg       Date:  2015-09       Impact factor: 4.129

2.  Surgical caloric restriction ameliorates mitochondrial electron transport dysfunction in obese females.

Authors:  Jing Li; Ritchie J Feuers; Varsha G Desai; Sherry M Lewis; Peter H Duffy; Martha A Mayhugh; George Cowan; Cynthia K Buffington
Journal:  Obes Surg       Date:  2007-06       Impact factor: 4.129

3.  Regional Adipose Distribution and its Relationship to Exercise Intolerance in Older Obese Patients Who Have Heart Failure With Preserved Ejection Fraction.

Authors:  Mark J Haykowsky; Barbara J Nicklas; Peter H Brubaker; W Gregory Hundley; Tina E Brinkley; Bharathi Upadhya; J Thomas Becton; Michael D Nelson; Haiying Chen; Dalane W Kitzman
Journal:  JACC Heart Fail       Date:  2018-07-11       Impact factor: 12.035

4.  Cardiopulmonary response to exercise in COPD and overweight patients: relationship between unloaded cycling and maximal oxygen uptake profiles.

Authors:  Abdoulaye Ba; Fabienne Brégeon; Stéphane Delliaux; Fallou Cissé; Abdoulaye Samb; Yves Jammes
Journal:  Biomed Res Int       Date:  2015-03-19       Impact factor: 3.411

5.  Severe Obesity Shifts Metabolic Thresholds but Does Not Attenuate Aerobic Training Adaptations in Zucker Rats.

Authors:  Thiago S Rosa; Herbert G Simões; Marcelo M Rogero; Milton R Moraes; Benedito S Denadai; Ricardo M Arida; Marília S Andrade; Bruno M Silva
Journal:  Front Physiol       Date:  2016-04-19       Impact factor: 4.566

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.